retatrutide phase 2 nejm 2023 obesity trial jastreboff π may be redefining treatment. New data from TRIUMPH-1 showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide Just Broke Every Obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14








:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)








,type=downsize)





